Bio-Techne Corporation Free Cash Flow 2009–2025
Bio-Techne Corporation reported $256.55M of free cash flow for fiscal 2025. That was 8.7% higher than fiscal 2024. Compared with fiscal 2020, the change was +67.2%.
| Fiscal year | Free Cash Flow | Change (YoY) |
|---|---|---|
| FY 2025 | $256.55M | +8.7% |
| FY 2024 | $236.10M | +9.2% |
| FY 2023 | $216.15M | -22.9% |
| FY 2022 | $280.36M | -8.9% |
| FY 2021 | $307.86M | +100.6% |
| FY 2020 | $153.47M | -1.8% |
| FY 2019 | $156.21M | +4.5% |
| FY 2018 | $149.43M | +16.3% |
| FY 2017 | $128.54M | +1.0% |
| FY 2016 | $127.26M | +6.5% |
| FY 2015 | $119.45M | -2.8% |
| FY 2014 | $122.94M | +21.6% |
| FY 2013 | $101.11M | -16.3% |
| FY 2012 | $120.73M | -2.3% |
| FY 2011 | $123.56M | +15.9% |
| FY 2010 | $106.62M | +1.8% |
| FY 2009 | $104.77M | — |
Source: Bio-Techne Corporation SEC filings — cash flow statement (10-K). Computed deterministically; refreshed nightly (last updated August 2, 2026). Open TECH 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
Bio-Techne Corporation reported $256.55M of free cash flow for fiscal 2025. That was 8.7% higher than fiscal 2024. Compared with fiscal 2020, the change was +67.2%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for Bio-Techne Corporation
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeBio-Techne Corporation — frequently asked questions
What is Bio-Techne Corporation's free cash flow?
Bio-Techne Corporation (TECH) reported free cash flow of $256.55M for fiscal year 2025, per its SEC filings.
How has Bio-Techne Corporation's free cash flow changed over time?
Between fiscal 2009 and 2025, TECH's free cash flow grew at roughly 5.8% per year (compound annual rate), from $104.77M to $256.55M.
Where does this data come from?
Figures are computed from Bio-Techne Corporation's official SEC filings (cash flow statement (10-K)), refreshed nightly. Not investment advice.